Skip to content
Disclosery

ORACLE INVESTMENT MANAGEMENT INC

Follow

13F filer, CIK 1012622, GREENWICH, CT

ORACLE INVESTMENT MANAGEMENT INC reported $150,492,951 across 27 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-15. Its ten largest share positions make up 97.13% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-24-002646

Period
2024-03-31
Reported value
$150M
Holdings
27
Top 10 weight
97.13%
New
6
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPRINGWORKS THERAPEUTICS INCadded+264,500$13M
WGSadded+948,253$8.66M
ARDXadded+1,175,000$8.58M
BHVNadded+88,423$4.84M
EYPTadded+60,300$1.25M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TDOCexited-112,861-$2.43M
QDELreduced-19,343-$927K
AGENUS INCreduced-350,000-$203K
VERTEX ENERGY INCexited-50,000-$170K
PACBreduced-20,769-$77.9K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2024

Share positions as resolved from 13F-HR 0001085146-24-002646, largest first. % of portfolio is the value over $124,210,626, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 804,850 shares 804,850$44M35.44%+88,423Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 421,583 shares 421,583$20.8M16.71%+264,500
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,039,700 shares 2,039,700$14.9M11.99%+1,175,000Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,126,607 shares 1,126,607$10.3M8.28%+948,253Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 461,857 shares 461,857$9.55M7.69%+60,300Timeline
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 157,201 shares 157,201$7.54M6.07%-19,343Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,356,026 shares 1,356,026$5.09M4.09%-20,769Timeline
FORAFORIAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,355,807 shares 1,355,807$4.5M3.62%-12,260Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 535,558 shares 535,558$2.72M2.19%0Timeline
IMMPIMMUTEP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 564,879 shares 564,879$1.32M1.06%+48,449Timeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 17,600 shares 17,600$1.23M0.99%newTimeline
AGENUS INCAGENUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,066,963 shares 1,066,963$619K0.5%-350,000
WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 27,500 shares 27,500$596K0.48%new
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,412 shares 2,412$520K0.42%0Timeline
OPTINOSE INCOPTINOSE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 325,000 shares 325,000$474K0.38%new
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 30,351 shares 30,351$43.4K0.03%-30,588
AXDXQACCELERATE DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 42,101 shares 42,101$41.7K0.03%-69,474Timeline
DERMTECH INCDERMTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 47,687 shares 47,687$33.5K0.03%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INC CALLcall410,000$8.89M+310,000
BIOHAVEN LTDBIOHAVEN LTD COMcall119,500$6.54M+44,500
XBISPDR SERIES TRUST S&P BIOTECHcall35,000$3.32Mnew
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC CALLcall42,900$2.11M-207,100
ARDELYX INCARDELYX INC COMcall270,900$1.98M-1,154,100
STAAR SURGICAL COSTAAR SURGICAL CO CALLcall35,000$1.34Mnew
PACIFIC BIOSCIENCES CALIF INPACIFIC BIOSCIENCES CALIF IN COMcall250,000$938K-1,537,100
EYEPOINT INCEYEPOINT INC CALLcall28,600$591K-191,700
PALANTIR TECHNOLOGIES INCPALANTIR TECHNOLOGIES INC CALLcall25,000$575Knew

Sold out in Q1 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TELADOC HEALTH INCTELADOC HEALTH INC639,600$13.8Mcall
QUIDELORTHO CORPQUIDELORTHO CORP172,100$12.7Mcall
TDOCTELADOC HEALTH INC112,861$2.43Mshares
VERTEX ENERGY INCVERTEX ENERGY INC50,000$170Kshares
INKTINKT36,898$39.5Kshares

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-24-002646 base2024-05-15acceptance time not in the bulk data set